The U.S. Food and Drug Administration (FDA) has lifted its hold on a late-stage trial for Novavax’s COVID-influenza combination and standalone flu vaccines, the company reported on Monday (NASDAQ:MNDY ...

The U.S. Food and Drug Administration has lifted its clinical hold on a late-stage trial of Novavax's COVID-influenza and its standalone flu vaccines, the company said on Monday.

Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M adjuvant, today ...

Novavax, Inc. (NASDAQ:NVAX – Get Free Report) has been assigned an average rating of “Hold” from the six brokerages that are presently covering the company, Marketbeat.com reports. One research ...

The World Health Organization will convene a meeting of its Emergency Committee next week to determine whether mpox remains a ...

Meanwhile, R21/Matrix-M is one of several ongoing collaborations involving Novavax’s adjuvant technology, with additional research in malaria and other infectious diseases in both humans and ...

The October consumer price index inflation data is out on Wednesday. Plus, earnings from Home Depot, Spotify, Instacart, ...

Flowserve Corporation ("Flowserve" or the "Company"), a leading provider of flow control products and services for the global infrastructure markets, announced today its participation in the following ...

Novavax, Inc. , a global company advancing protein-based vaccines with its Matrix-Mtm adjuvant, today announced that the U.S. Food and Drug Administration (FDA) has removed the clinical hold on ...

As the calendar approaches the middle of November, a lineup of major companies across various sectors is set to report their ...